Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Ptc Therapeutics (PTCT) Amortization - Intangibles (2017 - 2025)

Ptc Therapeutics (PTCT) has 9 years of Amortization - Intangibles data on record, last reported at $9.3 million in Q4 2025.

  • For Q4 2025, Amortization - Intangibles rose 182.7% year-over-year to $9.3 million; the TTM value through Dec 2025 reached $19.5 million, down 67.91%, while the annual FY2025 figure was $24.7 million, 59.26% down from the prior year.
  • Amortization - Intangibles reached $9.3 million in Q4 2025 per PTCT's latest filing, up from $3.8 million in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $77.2 million in Q4 2023 and bottomed at $2.9 million in Q2 2024.
  • Average Amortization - Intangibles over 5 years is $26.0 million, with a median of $19.9 million recorded in 2021.
  • Peak YoY movement for Amortization - Intangibles: plummeted 95.71% in 2024, then soared 182.7% in 2025.
  • A 5-year view of Amortization - Intangibles shows it stood at $16.3 million in 2021, then surged by 118.87% to $35.8 million in 2022, then skyrocketed by 115.79% to $77.2 million in 2023, then tumbled by 95.71% to $3.3 million in 2024, then surged by 182.7% to $9.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortization - Intangibles were $9.3 million in Q4 2025, $3.8 million in Q1 2025, and $3.3 million in Q4 2024.